-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$10.25587.92% Upside
Aziyo Biologics, Inc. Frequently Asked Questions
-
What analysts cover Aziyo Biologics, Inc.?
Aziyo Biologics, Inc. has been rated by research analysts at Truist Financial, Piper Sandler in the past 90 days.